
Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
(Senior) Director Global Medical Affairs
London, United Kingdom; Cambridge, US; Gaithersburg, US; Mainz, Germany | full time | Job ID: 11272
About the Role:
The (Senior) Director Global Medical Affairs is a senior individual contributor and strategic leader responsible for major medical workstreams, key strategic pillars, or important components of an oncology asset strategy. This role shapes medical direction within its remit, leads matrix collaboration, and often represents Medical Affairs in cross-functional discussions, but does not serve as the formal leader of the MAT in this role architecture.
Your Contribution:
- Lead major workstreams or strategic pillars within an oncology asset, indication, or disease-area strategy.
- Translate scientific and clinical data into strategic recommendations, medical priorities, and differentiated scientific positioning within assigned scope.
- Define or co-lead evidence generation priorities for specific pillars such as scientific communications, insight generation, publications, HEOR integration, or launch-related medical planning.
- Represent Medical Affairs in relevant cross-functional forums and drive alignment across key stakeholders.
- Support development and refinement of medical plans and key scientific narratives.
- Partner closely with Development, GPS, Scientific Communications, Publications, HEOR, and country or regional medical teams.
- Coach junior colleagues and contribute to functional capability building.
A Good Match: Education and qualifications
- MD, PharmD, PhD, or equivalent scientific / clinical qualification required.
- Strong oncology expertise required for Senior and Executive levels; relevant oncology experience required for Associate level.
- Additional leadership training or broad cross-functional experience is advantageous.
Experience
- Significant experience in oncology Medical Affairs, Clinical Development, or a related strategic medical role in pharma or biotech.
- Demonstrated ability to lead complex workstreams and influence matrix stakeholders.
- Experience in global or regional matrix organizations.
- Strong strategic thinking and ability to synthesize complex data into action.
Core competencies
- Strategic thinking
- Deep oncology knowledge
- Influence without authority
- Cross-functional leadership
- Data interpretation and synthesis
- Prioritization and judgment
- Executive communication
Leadership expectations
- Leads with clarity, accountability, and collaboration.
- Drives alignment across complex stakeholders.
- Develops junior colleagues and role-models BioNTech values.
Decision-making authority
- High degree of autonomy within workstream or pillar scope.
- Makes strategic recommendations and operational decisions within assigned remit.
- Escalates end-to-end MAT or franchise trade-offs to the Executive Medical Director / MAT Leader or VP as appropriate.
Key interactions
- Senior Global Medical Affairs colleagues
- Clinical Development
- Global Product Strategy
- HEOR
- Publications
- Scientific Communications
- US and International Medical teams
- Regulatory, Compliance, and Legal
Travel requirements
- Moderate to significant travel may be required for cross-functional meetings, congresses, and scientific engagement.
Your Benefits:
BioNTech is committed to the wellbeing of our team members and offers a variety of benefits in support of our diverse employee base. We offer competitive remuneration packages which is determined by the specific role, location of employment and also the selected candidate’s qualifications and experience.
Note: The availability, eligibility and design of the listed benefits may vary depending on the location. The final requirements for the individual use of our benefits are based on the company's internal policies and applicable law.
How to apply:
Apply now by sending us your application documents including Curriculum Vitae, copy of ID, copies of degree certificates and professional certificates, motivation letter as well as your contact details via our online form.
Please note:
Only applications sent via our online form shall be considered. By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
We are looking forward receiving your application.
閲覧数
1
応募クリック
0
Mock Apply
0
スクラップ
0
類似の求人

Senior Product Manager
Intercom · Dublin, Ireland

Solutions Director
HCL Technologies

Technical Program Manager, Infrastructure Deployment Software

Technical Program Manager, Radio Systems, Infrastructure

Technology Product Management - Senior Vice President
Citigroup · IRVING, Texas, United States of America
BioNTechについて

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
従業員数
Mainz that develops immunotherapies
本社所在地
$21.7B
企業価値
レビュー
10件のレビュー
4.0
10件のレビュー
ワークライフバランス
2.8
報酬
3.7
企業文化
4.2
キャリア
3.5
経営陣
3.3
78%
知人への推奨率
良い点
Innovative and cutting-edge technology projects
Supportive and collaborative team environment
Meaningful and impactful work with strong mission
改善点
Long working hours and high workload
Fast-paced environment can be stressful
High pressure and expectations
給与レンジ
38件のデータ
M3
M4
M5
M6
Mid/L4
Intern
L4
M3 · Product Manager M3
0件のレポート
$66,002
年収総額
基本給
$26,401
ストック
$33,001
ボーナス
$6,600
$46,201
$85,803
面接レビュー
レビュー1件
難易度
3.0
/ 5
期間
14-28週間
面接プロセス
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
よくある質問
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
最新情報
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease - WSJ
WSJ
News
·
2w ago
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
News
·
2w ago
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2w ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3w ago